Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Amgevita, adalimumab, Date of authorisation: 21/03/2017, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Amgevita, adalimumab, Date of authorisation: 21/03/2017, Revision: 14, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness